
SPI--112Me
CAS No. 1243685-62-2
SPI--112Me( —— )
Catalog No. M19354 CAS No. 1243685-62-2
SPI--112Me
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 81 | In Stock |
![]() ![]() |
10MG | 119 | In Stock |
![]() ![]() |
25MG | 205 | In Stock |
![]() ![]() |
50MG | 324 | In Stock |
![]() ![]() |
100MG | 486 | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameSPI--112Me
-
NoteResearch use only, not for human use.
-
Brief DescriptionSPI--112Me
-
DescriptionSPI--112Me
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayPI3K/Akt/mTOR signaling
-
TargetmTOR
-
RecptorPTPase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1243685-62-2
-
Formula Weight482.48
-
Molecular FormulaC23H19FN4O5S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESFc1ccc(cc1)CNS(=O)(=O)C2=CC=4C(C=C2)=NC(=O)C=4NNc3cc(ccc3)C(=O)OC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog



related products
-
XL413 hydrochloride
XL-413 is an orally bioavailable cell division cycle 7 homolog (CDC7) kinase inhibitor with potential antineoplastic activity.
-
MHY-1685
MHY-1685 is a mammalian target of rapamycin (mTOR) inhibitor and a senescence inhibitor that can rejuvenate senile hCSCs by modulating autophagy.
-
mTOR inhibitor-8
mTOR inhibitor-8 is a potent mTOR inhibitor and autophagy inducer with antiviral and antitumor activity. mTOR inhibitor-8 inhibits the growth of A549 cells, which can be used to study non-small cell lung cancer.